---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-001531"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T03:51:30.829223+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BGLC partners with ML Tech to optimize Ethereum treasury strategy

## Summary
- Partnership with ML Tech, an NFA-regulated AI wealth management platform, to optimize BGLC's Ethereum holdings.
- ML Tech will provide institutional-grade trading strategies with advanced quantitative models and non-custodial execution.
- Partnership follows BGLC's Ethereum treasury strategy to grow reserves while maintaining liquidity, transparency, and control.
- CEOs of both companies expressed commitment to digital asset innovation and enhancing shareholder value.

## SEC filing metadata
- accession: 0001477932-25-001531
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001531/0001477932-25-001531-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001531/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-001531
- JSON: https://secwatch.observer/filing/0001477932-25-001531.json
- Plain text: https://secwatch.observer/filing/0001477932-25-001531.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.